Canada Next-Generation Sequencing (NGS) Market - A Canada and Regional Analysis
Published Year: 2025
The Canada next-generation sequencing (NGS) market is projected to reach $2,776.2 million by 2035 from $381.6 million in 2024, growing at a CAGR of 19.40% during the forecast period 2025-2035.
$4900
Primary Highlights Of The Report
Canada Next-Generation Sequencing (NGS) Market Report Coverage
How can this report add value to an organization?
Canada Next-Generation Sequencing (NGS) Market Overview
Table of Contents
1 Canada Next-Generation Sequencing (NGS) Market: Industry Outlook
1.1 Trends: Current and Future Impact Assessment
1.1.1 Increasing Collaboration between Players, Government Bodies, Academia
1.1.2 Increasing Funding Scenario
1.2 Supply Chain Overview
1.3 Regulatory Framework
1.3.1 Canada National Regulatory
1.3.1.1 Provincial and Territorial Adaptations
1.3.1.2 Atlantic Canada (such as Nova Scotia, New Brunswick, Prince Edward Island, Newfoundland and Labrador)
1.3.1.3 Central Canada (Ontario and Quebec)
1.3.1.4 Northern Canada (such as Yukon, Northwest Territories, and Nunavut)
1.3.1.5 Western and Prairie Provinces (British Columbia, Alberta, Saskatchewan, Manitoba)
1.3.2 Best Practices and Guidelines
1.3.3 Regional Variations and Considerations
1.4 Patent Analysis
1.4.1 Patent Filing Trend (by Year)
1.5 Pricing Analysis
1.6 Genomic Projects in Canada
1.7 Emerging Technologies in NGS
1.8 Market Dynamics
1.8.1 Market Drivers
1.8.1.1 Increasing NGS-Based Testing Adoption in the Treatment of Cancer
1.8.1.2 Increasing Government Initiatives
1.8.1.3 Increased Applications in Healthcare and Research in Genetic Testing and Infectious Disease Monitoring
1.8.2 Market Restraints
1.8.2.1 High Costs and Resource Allocation
1.8.2.2 Data Complexity and Interpretation in NGS-Based Testing
1.8.3 Market Opportunities
1.8.3.1 Growing Advancements in Point-of-Care NGS
2 Canada Next-Generation Sequencing (NGS) Market (by Product Type), $Million, 2023-2035
2.1 Equipment
2.1.1 By Company
2.1.1.1 Illumina, Inc.
2.1.1.2 Thermo Fisher Scientific Inc.
2.1.1.3 Pacific Biosciences of California, Inc.
2.1.1.4 Oxford Nanopore Technologies plc.
2.1.1.4.1 Other Companies
2.1.2 By Throughput
2.1.2.1 High- and Ultra-High-Throughput
2.1.2.2 Medium-Throughput
2.1.2.2.1 Low-Throughput
2.2 Consumables
2.3 Services
3 Canada Next-Generation Sequencing (NGS) Market (by Technology), $Million, 2023-2035
3.1 Sequencing by Synthesis
3.2 Ion Torrent Semiconductor Sequencing
3.3 Single Molecule Real-Time (SMRT) Sequencing
3.4 Nanopore Sequencing Technology
3.5 Other Technologies
4 Canada Next-Generation Sequencing (NGS) Market (by Application), $Million, 2023-2035
4.1 Clinical Diagnostics
4.1.1 Oncology
4.1.2 Non-Oncology
4.1.2.1 Rare Diseases
4.1.2.2 Infectious Diseases
4.1.2.3 Reproductive Genetics
4.1.2.4 Other Non-Oncological Disorders
4.2 Research
4.2.1 Oncology
4.2.2 Non-Oncology
4.2.2.1 Rare Diseases
4.2.2.2 Infectious Diseases
4.2.2.3 Reproductive Genetics
4.2.2.4 Other Non-Oncological Disorders
5 Canada Next-Generation Sequencing (NGS) Market (by End User), $Million, 2023-2035
5.1 Academic and Research Institutes
5.2 Clinical Laboratories
5.3 Pharmaceutical and Biotechnology Companies
5.4 Other End Users
6 Canada Next-Generation Sequencing (NGS) Market (by Region), $Million, 2023-2035
6.1 Regional Summary
6.2 Atlantic Canada
6.2.1 Regional Overview
6.2.2 Driving Factors for Market Growth
6.2.3 Factors Challenging the Market
6.3 Central Canada
6.3.1 Regional Overview
6.3.2 Driving Factors for Market Growth
6.3.3 Factors Challenging the Market
6.4 Northern Canada
6.4.1 Regional Overview
6.4.2 Driving Factors for Market Growth
6.4.3 Factors Challenging the Market
6.5 Others Region
6.5.1 Regional Overview
6.5.2 Driving Factors for Market Growth
6.5.3 Factors Challenging the Market
7 Markets - Competitive Benchmarking & Company Profiles
7.1 Key Strategies and Development
7.2 Company Profiles
7.2.1 Illumina, Inc.
7.2.1.1 Overview
7.2.1.2 Top Products/Product Portfolio
7.2.1.3 Top Competitors
7.2.1.4 Target Customers
7.2.1.5 Key Personnel
7.2.1.6 Analyst View
7.2.2 Thermo Fisher Scientific Inc.
7.2.2.1 Overview
7.2.2.2 Top Products/Product Portfolio
7.2.2.3 Top Competitors
7.2.2.4 Target Customers
7.2.2.5 Key Personnel
7.2.2.6 Analyst View
7.2.3 QIAGEN N.V.
7.2.3.1 Overview
7.2.3.2 Top Products/Product Portfolio
7.2.3.3 Top Competitors
7.2.3.4 Target Customers
7.2.3.5 Key Personnel
7.2.3.6 Analyst View
7.2.4 Agilent Technologies, Inc.
7.2.4.1 Overview
7.2.4.2 Top Products/Product Portfolio
7.2.4.3 Top Competitors
7.2.4.4 Target Customers
7.2.4.5 Key Personnel
7.2.4.6 Analyst View
7.2.5 Oxford Nanopore Technologies plc.
7.2.5.1 Overview
7.2.5.2 Top Products/Product Portfolio
7.2.5.3 Top Competitors
7.2.5.4 Target Customers
7.2.5.5 Key Personnel
7.2.5.6 Analyst View
7.2.6 Pacific Biosciences of California, Inc.
7.2.6.1 Overview
7.2.6.2 Top Products/Product Portfolio
7.2.6.3 Top Competitors
7.2.6.4 Target Customers
7.2.6.5 Key Personnel
7.2.6.6 Analyst View
7.2.7 Danaher Corporation
7.2.7.1 Overview
7.2.7.2 Top Products/Product Portfolio
7.2.7.3 Top Competitors
7.2.7.4 Target Customers
7.2.7.5 Key Personnel
7.2.7.6 Analyst View
7.2.8 F. Hoffmann-La Roche Ltd.
7.2.8.1 Overview
7.2.8.2 Top Products/Product Portfolio
7.2.8.3 Top Competitors
7.2.8.4 Target Customers
7.2.8.5 Key Personnel
7.2.8.6 Analyst View
7.2.9 Singular Genomics Systems, Inc.
7.2.9.1 Overview
7.2.9.2 Top Products/Product Portfolio
7.2.9.3 Top Competitors
7.2.9.4 Target Customers
7.2.9.5 Key Personnel
7.2.9.6 Analyst View
7.2.10 Revvity, Inc.
7.2.10.1 Overview
7.2.10.2 Top Products/Product Portfolio
7.2.10.3 Top Competitors
7.2.10.4 Target Customers
7.2.10.5 Key Personnel
7.2.10.6 Analyst View
8 Research Methodology
8.1 Data Sources
8.1.1 Primary Data Sources
8.1.2 Secondary Data Sources
8.1.3 Data Triangulation
8.2 Market Estimation and Forecast
List of Tables
Table 1: Market Snapshot
Table 2: Canada Next-Generation Sequencing (NGS) Market Trend Analysis
Table 3: Collaborations in the Canada Next-Generation Sequencing (NGS) Market
Table 4: Funding Scenario in the Canada Next-Generation Sequencing (NGS) Market
Table 5: Comparison of the Medical Device Approval Processes Followed by Health Canada and the U.S. Food and Drug Administration (FDA)
Table 6: Listed Prices of Key NGS Platforms
Table 7: Canada Next-Generation Sequencing (NGS) Market (by Region), $Million, 2023-2035
Table 8: Key Strategies, January 2022-June 2025
List of Figures
Figure 1: Canada Next-Generation Sequencing (NGS) Market (by Scenario), $Million, 2024, 2028, and 2035
Figure 2: Canada Next-Generation Sequencing (NGS) Market (by End User), $Million, 2023, 2028, and 2035
Figure 3: Canada Next-Generation Sequencing (NGS) (by Offering), $Million, 2023, 2028, and 2035
Figure 4: Canada Next-Generation Sequencing (NGS) Market (by Technology), $Million, 2023, 2028, and 2035
Figure 5: Canada Next-Generation Sequencing (NGS) Market (by Application), $Million, 2023, 2028, and 2035
Figure 6: Canada Next-Generation Sequencing (NGS) Literature Published, January 2015 to June 2025
Figure 7: Canada Next-Generation Sequencing (NGS) Market Segmentation
Figure 8: Supply Chain and Risks within the Supply Chain
Figure 9: List of Common Raw Materials and Suppliers in the Canada Next-Generation Sequencing Market
Figure 10: Canada Next-Generation Sequencing (NGS) Market, Patent Analysis (by Year), January 2020-June 2025
Figure 11: Ontario Genomics: Diagnosing Rare Genetic Diseases in Children
Figure 12: All for One Precision Health Initiative
Figure 13: Pediatric Genomic Medicine Initiative (SickKids Hospital)
Figure 14: UBC’s New Genomics Projects for Disease Testing and Treatment
Figure 15: Long-Read Sequencing (LRS) Technologies
Figure 16: Single-Cell Sequencing
Figure 17: Real-Time Sequencing
Figure 18: Epigenomics and DNA Methylation Profiling
Figure 19: Impact Analysis of Market Navigating Factors, 2024-2035
Figure 20: Canada Next-Generation Sequencing (NGS) Market (by Offering), $Million, 2023, 2028, and 2035
Figure 21: Canada Next-Generation Sequencing (NGS) Market, Equipment, $Million, 2023-2035
Figure 22: Canada Next-Generation Sequencing (NGS) Market (Illumina, Inc.), $Million, 2023-2035
Figure 23: Canada Next-Generation Sequencing (NGS) Market (Illumina, Inc.), Units, 2023-2035
Figure 24: Canada Next-Generation Sequencing (NGS) Market (Thermo Fisher Scientific Inc.), $Million, 2023-2035
Figure 25: Canada Next-Generation Sequencing (NGS) Market (Thermo Fisher Scientific Inc.), Units, 2023-2035
Figure 26: Canada Next-Generation Sequencing (NGS) Market (Pacific Biosciences of California, Inc.), $Million, 2023-2035
Figure 27: Canada Next-Generation Sequencing (NGS) Market (Pacific Biosciences of California, Inc.), Units, 2023-2035
Figure 28: Canada Next-Generation Sequencing (NGS) Market (Oxford Nanopore Technologies plc.), $Million, 2023-2035
Figure 29: Canada Next-Generation Sequencing (NGS) Market (Oxford Nanopore Technologies plc.), Units, 2023-2035
Figure 30: Canada Next-Generation Sequencing (NGS) Market (Other Companies), $Million, 2023-2035
Figure 31: Canada Next-Generation Sequencing (NGS) Market (Other Companies), Units, 2023-2035
Figure 32: Features of Key High and Ultra High Throughput NGS Platforms
Figure 33: Canada Next-Generation Sequencing (NGS) Market (High- and Ultra-High-Throughput), $Million, 2023-2035
Figure 34: Features of Key Medium-Throughput NGS Platforms
Figure 35: Canada Next-Generation Sequencing (NGS) Market (Medium-Throughput), $Million, 2023-2035
Figure 36: Features of Key Low-Throughput NGS Platforms
Figure 37: Canada Next-Generation Sequencing (NGS) Market (Low-Throughput), $Million, 2023-2035
Figure 38: Canada Next-Generation Sequencing (NGS) Market, Consumables , $Million, 2023-2035
Figure 39: Canada Next-Generation Sequencing (NGS) Market, Services, $Million, 2023-2035
Figure 40: Canada Next-Generation Sequencing (NGS) Market (by Technology), $Million, 2023, 2028, and 2035
Figure 41: Canada Next-Generation Sequencing (NGS) Market, Sequencing by Synthesis, $Million, 2023-2035
Figure 42: Canada Next-Generation Sequencing (NGS) Market, Ion Torrent Semiconductor Sequencing, $Million, 2023-2035
Figure 43: Canada Next-Generation Sequencing (NGS) Market, Single Molecule Real-Time (SMRT) Sequencing, $Million, 2023-2035
Figure 44: Canada Next-Generation Sequencing (NGS) Market, Nanopore Sequencing Technology, $Million, 2023-2035
Figure 45: Canada Next-Generation Sequencing (NGS) Market, Other Technologies, $Million, 2023-2035
Figure 46: Canada Next-Generation Sequencing (NGS) Market (by Application), 2023, 2028, and 2035
Figure 47: Canada Next-Generation Sequencing (NGS) Market, Clinical Diagnostics, $Million, 2023-2035
Figure 48: Applications of NGS in Oncology
Figure 49: Canada Next-Generation Sequencing (NGS) Market, Clinical Diagnostics by Oncology, $Million, 2023-2035
Figure 50: Canada Next-Generation Sequencing (NGS) Market, Clinical Diagnostics by Non-Oncology, $Million, 2023-2035
Figure 51: Canada Next-Generation Sequencing (NGS) Market, Clinical Diagnostics by Rare Diseases, $Million, 2023-2035
Figure 52: Canada Next-Generation Sequencing (NGS) Market, Clinical Diagnostics by Infectious Diseases, $Million, 2023-2035
Figure 53: Canada Next-Generation Sequencing (NGS) Market, Clinical Diagnostics by Reproductive Genetics, $Million, 2023-2035
Figure 54: Canada Next-Generation Sequencing (NGS) Market, Clinical Diagnostics by Other Non-Oncological Disorders, $Million, 2023-2035
Figure 55: Canada Next-Generation Sequencing (NGS) Market, Research, $Million, 2023-2035
Figure 56: Canada Next-Generation Sequencing (NGS) Market, Research by Oncology, $Million, 2023-2035
Figure 57: Canada Next-Generation Sequencing (NGS) Market, Research by Non-Oncology, $Million, 2023-2035
Figure 58: Canada Next-Generation Sequencing (NGS) Market, Research by Rare Diseases, $Million, 2023-2035
Figure 59: Canada Next-Generation Sequencing (NGS) Market, Research by Infectious Diseases, $Million, 2023-2035
Figure 60: Canada Next-Generation Sequencing (NGS) Market, Research by Reproductive Genetics, $Million, 2023-2035
Figure 61: Canada Next-Generation Sequencing (NGS) Market, Research by Other Non-Oncological Disorders, $Million, 2023-2035
Figure 62: Canada Next-Generation Sequencing (NGS) Market (by End User), $Million, 2023, 2028, and 2035
Figure 63: Canada Next-Generation Sequencing (NGS) Market, Academic and Research Institutes, $Million, 2023-2035
Figure 64: Canada Next-Generation Sequencing (NGS) Market, Clinical Laboratories, $Million, 2023-2035
Figure 65: Canada Next-Generation Sequencing (NGS) Market, Pharmaceutical and Biotechnology Companies, $Million, 2023-2035
Figure 66: Canada Next-Generation Sequencing (NGS) Market, Other End Users, $Million, 2023-2035
Figure 67: Atlantic Next-Generation Sequencing (NGS) Market, $Million, 2023-2035
Figure 68: Central Canada Next-Generation Sequencing (NGS) Market, $Million, 2023-2035
Figure 69: Northern Canada Next-Generation Sequencing (NGS) Market, $Million, 2023-2035
Figure 70: Other Region Next-Generation Sequencing (NGS) Market, $Million, 2023-2035
Figure 71: Strategic Initiatives, January 2022-June 2025
Figure 72: Data Triangulation
Figure 73: Top-Down and Bottom-Up Approach
Figure 74: Assumptions and Limitations
